PortfoliosLab logoPortfoliosLab logo
BBP vs. MHIP
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

BBP vs. MHIP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Virtus LifeSci Biotech Products ETF (BBP) and Milliman Healthcare Inflation Plus ETF (MHIP). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


BBP

1D
0.42%
1M
-4.86%
6M
13.89%
YTD
17.95%
1Y
51.96%
3Y*
20.67%
5Y*
12.86%
10Y*
11.61%
ALL TIME*
12.18%

MHIP

1D
0.39%
1M
-0.68%
6M
YTD
1Y
3Y*
5Y*
10Y*
ALL TIME*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$934.12K$1.05M$1.02M
$1.34K$877.52$4.14K

BBP vs. MHIP - Yearly Performance Comparison


Correlation

The correlation between BBP and MHIP is 0.49, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (All Time)
Calculated using the full available price history since Apr 21, 2026

0.49

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BBP vs. MHIP — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

BBP
BBP Risk / Return Rank: 8888
Overall Rank
BBP Sharpe Ratio Rank: 8787
Sharpe Ratio Rank
BBP Sortino Ratio Rank: 8686
Sortino Ratio Rank
BBP Omega Ratio Rank: 8181
Omega Ratio Rank
BBP Calmar Ratio Rank: 9595
Calmar Ratio Rank
BBP Martin Ratio Rank: 9191
Martin Ratio Rank

MHIP

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

BBP vs. MHIP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Products ETF (BBP) and Milliman Healthcare Inflation Plus ETF (MHIP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


BBPMHIPDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.35

Calmar ratioReturn relative to maximum drawdown

5.55

Martin ratioReturn relative to average drawdown

15.50

BBP vs. MHIP - Sharpe Ratio Comparison


Loading charts...

Drawdowns

BBP vs. MHIP - Drawdown Comparison

The maximum BBP drawdown since its inception was -44.32%, which is greater than MHIP's maximum drawdown of -3.09%. Use the drawdown chart below to compare losses from any high point for BBP and MHIP.


Loading charts...

Drawdown Indicators


BBPMHIPDifference

Max Drawdown

Largest peak-to-trough decline

-44.32%

-3.09%

-41.23%

Max Drawdown (1Y)

Largest decline over 1 year

-9.41%

Max Drawdown (3Y)

Largest decline over 3 years

-26.09%

Max Drawdown (5Y)

Largest decline over 5 years

-37.77%

Max Drawdown (10Y)

Largest decline over 10 years

-44.32%

Current Drawdown

Current decline from peak

-9.03%

-1.02%

-8.01%

Average Drawdown

Average peak-to-trough decline

-11.90%

-1.30%

-10.60%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.36%

Volatility

BBP vs. MHIP - Volatility Comparison


Loading charts...

Volatility by Period


BBPMHIPDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.29%

Volatility (6M)

Calculated over the trailing 6-month period

19.11%

Volatility (1Y)

Calculated over the trailing 1-year period

24.10%

10.92%

+13.18%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

26.43%

10.92%

+15.51%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

27.35%

10.92%

+16.43%

BBP vs. MHIP - Expense Ratio Comparison

BBP has a 0.79% expense ratio, which is higher than MHIP's 0.55% expense ratio.


Dividends

BBP vs. MHIP - Dividend Comparison

Neither BBP nor MHIP has paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
BBP
Virtus LifeSci Biotech Products ETF
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.18%0.00%1.29%
MHIP
Milliman Healthcare Inflation Plus ETF
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


BBP and MHIP have a correlation of 0.49, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, MHIP is cheaper at 0.55% per year. The better choice depends on whether you care most about return, fees, risk, or income.

MHIP is cheaper with a 0.55% expense ratio, compared with 0.79% for BBP.

BBP and MHIP have nearly identical dividend yields, around 0.00%.

They also come from different issuers: Virtus and Milliman. Their fees differ too: 0.79% for BBP and 0.55% for MHIP.

Portfolio Optimizer

Find the right allocation for BBP and MHIP

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer